Stock · ACUTAAS · Healthcare
ACUTAAS share price target 2026
Support, resistance, the F&O structure and the BazaarBaazi Crack Score for ACUTAAS CHEMICALS LIMITED, refreshed every end-of-day run. A systematic, data-only read on ACUTAAS CHEMICALS LIMITED: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
The verdict
BazaarBaazi reads ACUTAAS as constructive with a Crack Score of 98/100 as of 21 Jul 2026.
BazaarBaaziSource & method
The scanner's readNear-perfect · scanned 21 Jul 2026
Where ACUTAAS stands on the 500-name BazaarBaazi setup scanner: technicals, filed fundamentals and money flow read together, refreshed every run.
One directional side cleared its price-structure, filed-evidence and signed money-flow gates with no blocking red flag.
Technical axis
100/100Fundamental axis
100/100Money flow
88/100Result pulse · Q4 FY26
100/100Named setups in force
- stage2 uptrend
- breakout 52w high
- under accumulation
- RS leader
- earnings acceleration
- quality margins
- growth underpriced
- result winner
Technical evidence
price above 50DMA
price above 150DMA
price above 200DMA
50 > 150 > 200 DMA (clean stack)
at/near 52w high (<=3% off)
RSI 66.1 (strong)
above a rising MA frame
not over-extended (<5 ATR over 50DMA)
money-flow score 88.3/100
Chaikin money flow +0.234 (accumulation)
up/down volume 2.01x (buyers dominant)
MFI 59.8
relative strength rising vs NIFTY
RS line near its highs (leadership)
RS slope +54.0% (3m)
outperforming and above 50DMA
Fundamental evidence
net profit +114.11% YoY
revenue +40.28% YoY
net margin 31.03%
result score 100.0/100
net margin 31.03% (high)
result score 100.0/100
profit not shrinking YoY
revenue +40.28% YoY
delivering more growth than priced (gap +11)
materially underpriced growth
real growth ~68%
result score 100.0/100
result score 100.0/100 (top tier)
strong filed quarter
profit up YoY
revenue up YoY
Valuation and context
P/E 84.5 vs sector median 50.4 (1.68x, 85th pctile)
P/E 2.32x its own ~15m median (36.5)
Relative valuation
P/E (TTM)
84.5P/E vs sector
+1.7%Sector percentile
85PEG
0.74Growth gap
+11.4%P/E vs own history
+2.3%The engine's trade frame
Entry zone
3,677.0Stop
3,431.2Target 1
4,168.7Target 2
4,414.5Risk / reward
6.7% risk · 2.0RScanner levels from the deterministic engine run of 2026-07-21, not a SEBI-registered recommendation and not investment advice. The fundamental axis reads the official filing: Q4 FY26 result.
Price target: support and resistanceComputed 21 Jul 2026
Support and resistance for ACUTAAS are read inside the latest show; no spot was printed in the most recent editorial note.
Levels are read inside the latest show. The most recent editorial reference is Systematic Read on 21 Jul 2026.
These are structural reference lines, not a SEBI-registered price target. BazaarBaazi is independent media; the levels frame how the desk reads the ACUTAAS chart, refreshed every end-of-day run.
The Crack Score, and how it is built98 / 100 · High conviction
The Crack Score is a deterministic 0 to 100 conviction number. Here is exactly what moved it for ACUTAAS, so the figure is a transparent signal rather than a vibe.
Base 50, adjusted by the factors above and clamped to 0 to 100. How the Crack Score works.
The F&O viewHorizon · swing
How the futures and options structure on ACUTAAS reads right now.
The editorial price read on ACUTAAS is bullish. Strike-level option inventory is unavailable, so the page withholds writer, wall and pin claims. Single-stock F&O on ACUTAAS can be thinner than index F&O, so the desk weights price and filed evidence over raw OI. This is not a derivatives trade recommendation.
Why it movedLatest editorial line
The most recent BazaarBaazi read on what is driving ACUTAAS.
Systematic read: a disclosed, data-only model on real 1-year price structure.
Read in Systematic Read on 21 Jul 2026. Why ACUTAAS moved, the living explainer, tracks every move on one URL.
Latest filed resultsQ4 FY26
ACUTAAS CHEMICALS LIMITED's most recent quarter, parsed straight from the official NSE filing. Every figure links back to its primary source.
Result Pulse
100 / 100Revenue
Rs 433 crNet profit
Rs 134 crEPS (quarter)
Rs 16.09| Growth | YoY | QoQ |
|---|---|---|
| Revenue | +40.3% | +10.1% |
| Net profit | +114.1% | +26.4% |
| Net margin | +31.0% | |
Figures are the Q4 FY26 result for ACUTAAS CHEMICALS LIMITED, parsed straight from the official NSE integrated filing and verified to the paisa. The EPS shown is for the quarter, not a trailing-twelve-month figure, so it is not a P/E input.
Earnings history, every filed quarter19 quarters on record
ACUTAAS CHEMICALS LIMITED's official quarterly revenue, EPS and Result Pulse trail, every quarter the desk holds from the verified filings export, back to 30 Sep 2021. These are quarterly facts, not TTM valuation inputs.
ACUTAAS official result trail
19 quarters
Quarterly figures only: revenue, net profit and EPS are copied from official filings. EPS here is not trailing twelve month EPS and is not used for valuation.
| Quarter | Revenue | EPS | PAT YoY | Pulse | Source |
|---|---|---|---|---|---|
| Q4 FY26ended 31 Mar 2026 / Consolidated, audited | Rs 433 cr | Rs 16.09 | n/a | n/a | Filing |
| Q3 FY26ended 31 Dec 2025 / Consolidated, audited | Rs 393 cr | Rs 13.19 | n/a | 68/100 | Filing |
| Q2 FY26ended 30 Sep 2025 / Consolidated, audited | Rs 306 cr | Rs 8.82 | n/a | 68/100 | Filing |
| Q1 FY26ended 30 Jun 2025 / Consolidated, audited | Rs 207 cr | Rs 5.41 | n/a | 58/100 | Filing |
| Q4 FY25ended 31 Mar 2025 / Consolidated, audited | Rs 308 cr | Rs 7.80 | n/a | 58/100 | Filing |
| Q3 FY25ended 31 Dec 2024 / Consolidated, audited | Rs 275 cr | Rs 11.35 | n/a | n/a | Filing |
| Q2 FY25ended 30 Sep 2024 / Consolidated, audited | Rs 247 cr | Rs 9.38 | n/a | n/a | Filing |
| Q1 FY25ended 30 Jun 2024 / Consolidated, audited | Rs 177 cr | Rs 3.67 | n/a | n/a | Filing |
| Q4 FY24ended 31 Mar 2024 / Consolidated, audited | Rs 225 cr | Rs 6.86 | n/a | n/a | Filing |
| Q3 FY24ended 31 Dec 2023 / Consolidated, audited | Rs 166 cr | Rs 4.83 | n/a | n/a | Filing |
| Q2 FY24ended 30 Sep 2023 / Consolidated, audited | Rs 172 cr | Rs -4.67 | n/a | n/a | Filing |
| Q1 FY24ended 30 Jun 2023 / Consolidated, audited | Rs 142 cr | Rs 4.57 | n/a | n/a | Filing |
| Q4 FY23ended 31 Mar 2023 / Consolidated, audited | Rs 186 cr | Rs 7.46 | n/a | n/a | Filing |
| Q3 FY23ended 31 Dec 2022 / Consolidated, audited | Rs 152 cr | Rs 6.28 | n/a | n/a | Filing |
| Q2 FY23ended 30 Sep 2022 / Consolidated, audited | Rs 147 cr | Rs 5.50 | n/a | n/a | Filing |
| Q1 FY23ended 30 Jun 2022 / Consolidated, audited | Rs 131 cr | Rs 4.08 | n/a | n/a | Filing |
| Q4 FY22ended 31 Mar 2022 / Consolidated, audited | Rs 144 cr | Rs 6.22 | n/a | n/a | Filing |
| Q3 FY22ended 31 Dec 2021 / Consolidated, audited | Rs 141 cr | Rs 5.69 | n/a | n/a | Filing |
| Q2 FY22ended 30 Sep 2021 / Consolidated, audited | Rs 122 cr | Rs 5.11 | n/a | n/a | Filing |
The official financialsFiled to 31 Mar 2026
ACUTAAS CHEMICALS LIMITED's statements as filed: trailing twelve month P&L, the balance sheet, and the cash engine. Parsed from official XBRL, shown in crore.
Trailing twelve months, on filed quarters
Revenue (TTM)
1,339 crNet profit (TTM)
356 crEBIT (TTM)
486 crProfit before tax (TTM)
483 crNet margin (TTM)
26.6%Finance costs (TTM)
3.3 crBalance sheet, as filed 2026-03-31
Total assets
1,984 crShareholder equity
1,711 crTotal borrowings
26.5 crCash and equivalents
216 crInventory
231 crTrade receivables
363 crThe cash engine, latest filed year
Operating cash flow
292 crCapex
328 crFree cash flow
-35.8 crInvesting flow
-266 crFinancing flow
4.1 crAnnual trail, filed year over filed year
| Year | Revenue | Net profit | Equity | Borrowings | CFO |
|---|---|---|---|---|---|
| FY26 | 1,339 cr | 356 cr | 1,711 cr | 26.5 cr | 292 cr |
| FY25 | 1,007 cr | 160 cr | 1,320 cr | 8.2 cr | 118 cr |
| FY24 | 717 cr | 48.7 cr | 683 cr | 217 cr | 125 cr |
| FY23 | 617 cr | 83.3 cr | 594 cr | 3.6 cr | 65.5 cr |
| FY22 | 520 cr | 71.9 cr | 522 cr | 0.8 cr | -8.7 cr |
Every figure is parsed from ACUTAAS CHEMICALS LIMITED's official NSE XBRL filings by the BazaarBaazi earnings lab and shown in crore rupees. Display data, not a valuation model input.
Management on record19 earnings calls
Every ACUTAAS earnings call BazaarBaazi has indexed, latest 31 May 2026. Read management in its own words, straight from the filed transcript.
ACUTAAS CHEMICALS LIMITED earnings calls on record
19 calls since 31 Oct 2021
Show 11 older calls
Each entry links to the transcript PDF the company filed with the exchange. Primary sources, in management's own words.
What changed29 disclosures
Every recent official filing from ACUTAAS CHEMICALS LIMITED, straight from the exchange feed, with the BazaarBaazi Event Heat on the disclosure flow.
ACUTAAS CHEMICALS LIMITED has filed 29 official disclosures recently. The most recent is a Investor meet dated 20 Jul 2026.
Event Heat
42 / 100Schedule of meet scheduled on July 24, 2026 at 04.00 P.M. (IST)
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Change in status ofAcutaas Chemicals Electrolytes Private Limited from Wholly owned Subsidiary to Subsidiary ofAcutaas Chemicals Limited
Event Heat is a dated net read of ACUTAAS CHEMICALS LIMITED's last 90 days of official disclosures, balancing the constructive filings against the ones to watch. It is a signal from what the company has filed, not investment advice. Every line above links to its official exchange filing, and the full market desk is at the disclosures hub.
Key fundamentalsEditorial reference
The anchor data BazaarBaazi references when reading the ACUTAAS chart. Not a substitute for a registered research note.
| Ticker | ACUTAAS |
|---|---|
| Full name | ACUTAAS CHEMICALS LIMITED |
| Sector | Healthcare |
| Index class | MID CAP |
| ISIN | INE00FF01025 |
| Market-cap band | ~30,687 cr (indicative) |
| Last referenced level | Inside latest show |
| Last session move | Not referenced this cycle |
| Editorial line in | Systematic Read on 21 Jul 2026 |
| Aliases tracked | ACUTAAS |
Reference chartLevels in show
The daily frame the desk reads on ACUTAAS.
FAQ13 reader questions · AEO-eligible
The line on ACUTAAS, distilled and schema-marked for AI Overview, Perplexity, and reader search.
What is the ACUTAAS share price target for 2026?
BazaarBaazi does not publish a SEBI-registered price target on ACUTAAS. The desk reads structural support and resistance inside each show against the printed spot; the most recent editorial line is Systematic Read on 21 Jul 2026.
What is BazaarBaazi's Crack Score for ACUTAAS?
The BazaarBaazi Crack Score for ACUTAAS is 98 out of 100 as of 21 Jul 2026, a high conviction reading. It is a computed conviction number from the signed stance, how consistent the recent verdicts have been, the quality of the printed structure, and how fresh the review is. It is a transparency signal, not investment advice.
What is the F&O view on ACUTAAS?
Strike-level option inventory for ACUTAAS is unavailable, so BazaarBaazi withholds participant, direction and positioning claims. The editorial chart stance is not substituted for an option-chain observation.
What sector is ACUTAAS in and which peers does BazaarBaazi track?
ACUTAAS sits in Healthcare (mid cap), indicative market cap ~30,687 cr (indicative), ISIN INE00FF01025. The peers BazaarBaazi reads alongside it are GLAND PHARMA LIMITED, Eris Lifesciences Limited, IPCA LABORATORIES LIMITED. A systematic, data-only read on ACUTAAS CHEMICALS LIMITED: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
How often is the ACUTAAS view updated?
This page is one evergreen URL refreshed in place. The Crack Score and levels re-compute on every BazaarBaazi end-of-day run, and the dated stamp shows the last refresh. The latest signed verdict on ACUTAAS is bullish, published in Systematic Read on 21 Jul 2026.
Is ACUTAAS a qualifying setup on the BazaarBaazi scanner right now?
On the 2026-07-21 run of the 500-name BazaarBaazi setup scanner, ACUTAAS CHEMICALS LIMITED sits in the Near-perfect tier with a setup score of 98/100 (technical 100, fundamental 100). The scanner is a deterministic engine over real OHLCV and official filings, refreshed nightly, and it is a signal rather than investment advice.
Where can I read ACUTAAS CHEMICALS LIMITED's earnings call transcripts?
BazaarBaazi indexes 19 ACUTAAS earnings calls going back to 2021-10-31, latest 2026-05-31. Every entry on this page links straight to the transcript PDF the company filed with the exchange, so you read management in the primary source.
What was ACUTAAS CHEMICALS LIMITED's Q4 FY26 net profit?
ACUTAAS CHEMICALS LIMITED reported a net profit of Rs 134 cr for Q4 FY26 (the quarter ended 31 March 2026). That is +114.1% year on year. The figure is from the company's official NSE filing.
What was ACUTAAS CHEMICALS LIMITED's Q4 FY26 revenue?
ACUTAAS CHEMICALS LIMITED reported revenue of Rs 433 cr for Q4 FY26. That is +40.3% year on year. The figure is from the company's official NSE filing.
How does BazaarBaazi rate ACUTAAS CHEMICALS LIMITED's Q4 FY26 result?
BazaarBaazi gives ACUTAAS CHEMICALS LIMITED's Q4 FY26 result a Result Pulse of 100 out of 100, with a verdict of Profit acceleration. The Result Pulse is a BazaarBaazi editorial score for the quality of the filed result, not investment advice.
What has Acutaas Chemicals Ltd announced recently?
Acutaas Chemicals Ltd's two most material recent disclosures are an investor meet dated 20 Jul 2026, "Schedule of meet scheduled on July 24, 2026 at 04.00 P.M.…", and a regulatory dated 10 Jul 2026, "Certificate under Regulation 74(5) of SEBI (Depositories…". Both link to the company's own official filing on the BazaarBaazi stock page.
Has Acutaas Chemicals Ltd declared a dividend recently?
Yes. Acutaas Chemicals Ltd filed a dividend disclosure on 30 Apr 2026, filed as "General Updates - Board approves Final Dividend". Any amount shown is the exchange's own record, linked from the BazaarBaazi stock page. A dividend is a declared payout, not a forecast of future returns.
What did Acutaas Chemicals Ltd's latest board meeting cover?
Acutaas Chemicals Ltd's most recent board-meeting disclosure on record dated 30 Apr 2026 reads "Board Meeting to be held on 30-Apr-2026 to consider and approve the…". That is the agenda as filed with the exchange, linked from the BazaarBaazi stock page, and BazaarBaazi adds no claim of its own to it.
Related stock views
The names BazaarBaazi reads alongside ACUTAAS, each a living view refreshed every end-of-day run.